![Mark McDonnell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark McDonnell
Plus aucun poste en cours
Health Technology
Profil
Mark McDonnell worked as Chief Chemist at Neuropathix, Inc. Former job includes Chief Chemist at Neuropathix, Inc.
Anciens postes connus de Mark McDonnell
| Sociétés | Poste | Fin |
|---|---|---|
| NEUROPATHIX, INC. | Corporate Officer/Principal | 01/09/2024 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Neuropathix, Inc.
 Neuropathix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapeutics for inflammatory & neuropathic pain related diseases | Health Technology |
